MG217 Multi-Symptom Treatment Cream & Skin Protectant — Class I drug recall D-0553-2026
Ongoing recall by Wisconsin Pharmacal Company, reported 2026-05-27, distributed nationwide. Microbial Contamination of Non-Sterile Products: confirmed presence of Staphylococcus Aureus.
| Recall number | D-0553-2026 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Wisconsin Pharmacal Company, Jackson, WI, United States |
| Recall initiated | 2026-04-24 |
| Classified | 2026-05-29 |
| Reported by FDA | 2026-05-27 |
| Distributed | Nationwide (US) |
| Countries outside the US | BS |
| Quantity | 690 tubes |
| Reason classes | microbial contamination, sterility |
| Pathogens | staphylococcus |
| Lot numbers | 1024088 |
| Expiration dates | 2026-11-30 |
Product
MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%), NET WT 6 oz (170 g), Manufactured by: Pharmacal 1 Pharmacal Way, P.O. Box 198, Jackson, WI 53037.
Reason for recall
Microbial Contamination of Non-Sterile Products: confirmed presence of Staphylococcus Aureus.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0553-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.